MTOR and cancer: Data from publicly available large-scale sequencing studies have shown that genetic alterations in drug targets, cell death and major cancer driving pathways, e.g., PI3K/AKT/MTOR or RAS/MAPK, and nuclear receptors can be found across all cancer types; however, at highly variable frequencies [14].